Literature DB >> 18385915

[Lupus vulgaris manifestation as a destructive nose and facial tumor].

D Haller1, C Reisser.   

Abstract

Lupus vulgaris is the most frequent manifestation of cutaneous tuberculosis, but in Europe it is limited to isolated cases. Mainly immunocompetent individuals are affected by this result of an endogenous reinfection on a lymphogenous-less frequently hematogenous-pathway. Lupus vulgaris has been observed to develop in more than 50% of all patients who already suffer from other manifestations of tuberculosis. The development of a squamous cell carcinoma in the lupus vulgaris is a rare complication; therefore, lupus vulgaris is deemed a facultative precancerosis.A 68-year-old female Serbo-Croatian patient presented with an extensive ulcerative nose and facial tumor. Her anamnesis included a squamous cell carcinoma of the nose that had been excised alio loco 3 years before. Further examinations revealed enlarged cervical lymphoma on both sides, and pulmonary metastases were also suspected. The tumor biopsy revealed a necrotic, granulomatous inflammation. No acid-fast rods were seen on Ziehl-Neelsen stain. The tuberculous origin of this ulcerative skin tumor-the lupus vulgaris-as an endogenous reinfection of pulmonary tuberculosis manifestation was confirmed by the detection of Mycobacterium tuberculosis DNA in polymerase chain reaction and the growth of Mycobacterium tuberculosis colonies in the bacterial culture (skin biopsy and bronchial secretion). The skin tumor as well as the pulmonary manifestation were successfully treated with combined tuberculostatic therapy and showed a dramatic response within 3 months.

Entities:  

Mesh:

Year:  2009        PMID: 18385915     DOI: 10.1007/s00106-008-1716-z

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  13 in total

1.  Polymerase chain reaction based detection of Mycobacterium tuberculosis complex in lupus vulgaris: a case report.

Authors:  O Baylan; E Arca; A Ozcan; O Kisa; A Albay; L Doganci
Journal:  Int J Tuberc Lung Dis       Date:  2004-09       Impact factor: 2.373

2.  Lupus vulgaris--report of a case with facial involvement.

Authors:  S Thomas; S Suhas; K M Pai; A R Raghu
Journal:  Br Dent J       Date:  2005-02-12       Impact factor: 1.626

3.  Lupus vulgaris--a case diagnosed more than 20 years after onset.

Authors:  Adel Sammain; Andrea Jocher; Leena Bruckner-Tuderman; Christoph M Schempp
Journal:  J Dtsch Dermatol Ges       Date:  2006-11       Impact factor: 5.584

4.  Detection of Mycobacterium tuberculosis complex DNA by the polymerase chain reaction for rapid diagnosis of cutaneous tuberculosis.

Authors:  N Margall; E Baselga; P Coll; M A Barnadas; J M de Moragas; G Prats
Journal:  Br J Dermatol       Date:  1996-08       Impact factor: 9.302

5.  [Lupus tuberculosis: a cause of medio-facial mutilation not to be ignored].

Authors:  P Niamba; A Traoré; F Traoré-Barro; L Ilboudo; M Bonkoungou; G Diatto; P K Ouoba; O Goumbri-Lompo
Journal:  Bull Soc Pathol Exot       Date:  2006-07

6.  Lupus vulgaris. Clinical, histopathologic, and bacteriologic study of 10 cases.

Authors:  J Marcoval; O Servitje; A Moreno; A Jucglà; J Peyrí
Journal:  J Am Acad Dermatol       Date:  1992-03       Impact factor: 11.527

7.  [The demonstration of tuberculosis using molecular genetic methods polymerase chain reaction (PCR) and Amplified Mycobacterium tuberculosis direct (AMTD) test].

Authors:  Sárka Lásiková; Markéta Buncová; Blanka Sýkorov; Alice Gabrielová; Blanka Horová; Elka Nycová; Alice Machová; Lenka Moravcová
Journal:  Klin Mikrobiol Infekc Lek       Date:  2006-10

8.  Tuberculosis: a global overview of the situation today.

Authors:  P Sudre; G ten Dam; A Kochi
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

9.  Tuberculosis: distribution, risk factors, mortality.

Authors:  A Kochi
Journal:  Immunobiology       Date:  1994-10       Impact factor: 3.144

10.  Lupus vulgaris: unusual presentations over the face.

Authors:  S Khandpur; B S N Reddy
Journal:  J Eur Acad Dermatol Venereol       Date:  2003-11       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.